161 related articles for article (PubMed ID: 30987774)
21. Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma.
Le X; Wang XB; Zhao H; Chen RF; Ge P
BMC Urol; 2020 Sep; 20(1):148. PubMed ID: 32933514
[TBL] [Abstract][Full Text] [Related]
22. Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Urol Oncol; 2020 May; 38(5):506-514. PubMed ID: 32139292
[TBL] [Abstract][Full Text] [Related]
23. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
24. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis.
Yang C; Shuch B; Kluger H; Humphrey PA; Adeniran AJ
Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
26. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
27. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract][Full Text] [Related]
28. Associations between tumor grade, contrast-enhanced ultrasound features, and microvascular density in patients with clear cell renal cell carcinoma: a retrospective study.
Meng X; Yang R; Zhao S; Sun Z; Wang H
Quant Imaging Med Surg; 2022 Mar; 12(3):1882-1892. PubMed ID: 35284253
[TBL] [Abstract][Full Text] [Related]
29. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
[TBL] [Abstract][Full Text] [Related]
30. Prediction of World Health Organization /International Society of Urological Pathology (WHO/ISUP) Pathological Grading of Clear Cell Renal Cell Carcinoma by Dual-Layer Spectral CT.
Zhang X; Zhang G; Xu L; Bai X; Zhang J; Chen L; Lu X; Yu S; Jin Z; Sun H
Acad Radiol; 2023 Oct; 30(10):2321-2328. PubMed ID: 36543688
[TBL] [Abstract][Full Text] [Related]
31. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
32. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
33. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
34. Assessment of predictors of renal cell carcinoma progression after nephrectomy at short- and medium-term follow-up and implication on surveillance protocols.
Perri D; Palumbo C; Billia M; Umari P; Zacchero M; D'Agate D; Bondonno G; Volpe A
Minerva Urol Nephrol; 2022 Oct; 74(5):599-606. PubMed ID: 34114786
[TBL] [Abstract][Full Text] [Related]
35. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
36. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies.
Warren AY; Harrison D
World J Urol; 2018 Dec; 36(12):1913-1926. PubMed ID: 30123932
[TBL] [Abstract][Full Text] [Related]
37. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
Murase Y; Iwata H; Takahara T; Tsuzuki T
Pathol Int; 2020 Dec; 70(12):984-991. PubMed ID: 32997867
[TBL] [Abstract][Full Text] [Related]
38. Gleason and Fuhrman no longer make the grade.
Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
[TBL] [Abstract][Full Text] [Related]
39. Incidence and long-term prognosis of papillary renal cell carcinoma.
Schrader AJ; Rauer-Bruening S; Olbert PJ; Hegele A; Rustemeier J; Timmesfeld N; Varga Z; Hofmann R
J Cancer Res Clin Oncol; 2009 Jun; 135(6):799-805. PubMed ID: 19023595
[TBL] [Abstract][Full Text] [Related]
40. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.
Liu N; Gan W; Qu F; Wang Z; Zhuang W; Agizamhan S; Xu L; Yin J; Guo H; Li D
Am J Pathol; 2018 Apr; 188(4):929-936. PubMed ID: 29571325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
